1,295
Views
67
CrossRef citations to date
0
Altmetric
Research Article

Polyelectrolyte Biomaterial Interactions Provide Nanoparticulate Carrier for Oral Insulin Delivery

, , , &
Pages 127-139 | Received 10 May 2007, Accepted 15 Jul 2007, Published online: 10 Oct 2008

REFERENCES

  • Becherán-Marón L., Peniche C., Argüelles-Monal W. Study of the interpolyelectrolyte reaction between chitosan and alginate: Influence of alginate composition and chitosan molecular weight. Int. J. Biol. Macromol. 2004; 34: 127–133
  • Boonsongrit Y., Mitrevej A., Mueller B. W. Chitosan drug binding by ionic interaction. Eur. J. Pharm. Biopharm. 2006; 62: 267–274
  • Burting P. Nutrional value of seaweeds. EJEAFChe 2003; 2: 498–503
  • Chen Y., Mohanraj V. J., Parkin J. E. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide. Let. Pept. Sci. 2003; 10: 621–629
  • Chien Y. W. Human insulin: basic sciences to therapeutic uses. Drug Dev. Ind. Pharm. 1996; 22: 753–789
  • Coppi G., Iannuccelli V., Leo E., Bernabei M. T., Cameroni R. Chitosan-alginate microparticles as a protein carrier. Drug Dev. Ind. Pharm. 2001; 27: 393–400
  • Damgé C., Maincent P., Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J. Control. Rel. 2007; 117: 163–170
  • Damgé C., Michel C., Aprahamian M., Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988; 37: 246–251
  • Donini C., Robinson D. N., Colombo P., Giordano F., Peppas N. A. Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications. Int. J. Pharm. 2002; 245: 83–91
  • Draget K. I., Skjåk-Braek G., Smidsrød O. Alginic acid gels: the effect of alginate chemical composition and molecular weight. Carbohydr. Polym. 1994; 25: 31–38
  • Gaserod O., Smidsrod O., Skjak-Braek G. Microcapsules of alginate-chitosan-I. A quantitative study of the interaction between alginate and chitosan. Biomaterials 1998; 19: 1815–25
  • Gursoy A., Cevik S. Sustained release properties of alginate microspheres and tabletted microspheres of diclofenac sodium. J. Microencapsul. 2000; 17: 565–575
  • Hari P. R., Chandy T., Sharma C. P. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencapsul. 1996; 13: 319–29
  • Hasegawa M., Yagi K., Iwakawa S., Hirai M. Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. J. Cancer Res. 2001; 92: 459–466
  • Janes K. A., Fresneau M. P., Marazuela A., Fabra A., Alonso M. J. Chitosan nanoparticles as delivery system for doxorubicin. J. Control. Rel. 2001; 73: 255–267
  • Jerry N., Anitha Y., Sharma C. P., Sony P. In vivo absorption studies of insulin from an oral delivery system. Drug Deliv. 2001; 8: 19–23
  • Lee D. W., Hwang S. J., Park J. B., Park H. J. Preparation and release characteristics of polymer-coated and blended alginate microspheres. J. Microencapsul. 2003; 20: 179–92
  • Lee K. Y., Park W. H., Ha W. S. Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives for microcapsules. J. Appl. Polym. Sci. 1997; 63: 425–432
  • Lerco M. M., Spadella C. T., Machado J. L. M., Schellini S. A., Pavodini C. R. Caracterização de um modelo experimental dediabetes mellitus, induzido pela aloxana em ratos. Estudo clínico e laboratorial. Acta Cirúrg. Brasil 2003; 18: 136–142
  • Mesiha M. S., Sidhom M. B., Fasipe B. Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles. Int. J. Pharm. 2005; 288: 289–293
  • Murata Y., Maeda T., Miyamoto E., Kawashima S. Preparation of chitosan-reinforced alginate gel beads—effects of chitosan on gel matrix erosion. Int. J. Pharm. 1993; 96: 139–145
  • Murata Y., Miyamoto E., Kawashima S. Additive effect of chondroitin sulfate and chitosan on drug release from calcium-induced alginate gel beads. J. Control. Rel. 1996; 38: 101–108
  • Norris D. A., Puri N., Sinko P. J. Effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliv. Rev. 1998; 34: 135–154
  • Ohta A., Taguchi A., Takizawa T., Adachi T., Kimura S., Hashizume N. The alginate reduce the postprandial glycaemic response by forming a gel with dietary calcium in the stomach of the rat. Int. J. Vitam. Nutr. Res. 1997; 67: 55–61
  • Polk A., Amsden B., Yao K. D., Peng T., Goosen M. F. A. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 1994; 83: 178–185
  • Prista L. N., Alves A. C., Morgado R. Tecnologia Farmacêutica. Fundação Calouste Gulbenkian, Lisboa 1995
  • Quong D., Neufeld R. J. DNA protection from extracapsular nuclease, within chitosan-or poly-l-lysine -coated alginate beads. Biotechnol. Bioeng. 1998; 60: 124–134
  • Quong D., Neufeld R. J., Skjak-Braek G., Poncelet D. External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation. Biotechnol. Bioeng. 1998; 57: 438–446
  • Reis C. P., Neufeld R. J., Ribeiro A. J., Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomed. Nanotechnol., Biol. Med. 2006a; 2: 53–65
  • Reis C. P., Neufeld R. J., Ribeiro A. J., Veiga F. Design of insulin-loaded alginate nanoparticles: influence of calcium ion on polymer gel matrix properties. Chem. Ind. Chem. Eng. Quart. 2006b; 12: 47–52
  • Reis C. P., Ribeiro A. J., Houng S., Veiga F., Neufeld R. J. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity. Eur. J. Pharm. Sci. 2007; 30: 392–397
  • Reis C. P., Ribeiro A. J., Neufeld R. J., Veiga F. Alginate microparticles as novel carrier for oral insulin delivery. Biotechnol. Bioeng. 2006c; 96: 977–989
  • Saez A., Guzman M., Molpeceres J., Aberturas M. R. Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur. J. Pharm. Biopharm. 2000; 50: 379–387
  • Sajeesh S., Sharma C. P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 2006; 325: 147–154
  • Sankalia M., Mashru R., Sankalia J., Sutariya V. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization. Eur. J. Pharm. Biopharm. 2006; 65: 215–32
  • Schechter Y., Mironchik M., Rubinraut S., Saul A., Tsubery H., Fridkin M. Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin. Bioconjug. Chem. 2005; 16: 913–920
  • Sezer A. D., Akbuga J. Release characteristics of chitosan treated alginate beads: Ii. Sustained release of a low molecular drug from chitosan treated alginate beads. J. Microencapsul. 1999; 16: 687–696
  • Shen W. H., Xu R. J. Gastrointestinal stability and absorption of insulin in suckling pigs. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2000; 125: 389–401
  • Silva C. M., Ribeiro A. J., Ferreira D., Veiga F. Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation. Eur. J. Pharm. Sci. 2006; 29: 148–159
  • Smitha B., Sridhar S., Khan A. A. Chitosan-sodium alginate polyion complexes as fuel cell membranes. Eur. Polym. J. 2005; 41: 1859–1866
  • Takahashi T., Takayama K., Machida Y., Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int. J. Pharm. 1990; 61: 35–41
  • Tapia C., Escobar Z., Costa E., Sapag-Hagar J., Valenzuela F., Busualto C., Gai M. N., Yazdani-Pedram M. Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems. Eur. J. Pharm. Biopharm. 2004; 57: 65–75
  • Tiyaboonchai W., Woiszwillo J., Sims R. C., Middaugh C. R. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int. J. Pharm. 2003; 255: 139–151
  • Zohuriaan M. J., Shokrolahi F. Thermal studies on natural and modified gums. Polym. Test. 2004; 23: 575–579

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.